During the past decade, Saint Vincent Hospital Cancer Center at Saint Mary's conducted 102 clinical trials. In the 10-year time frame, 102 clinical trials started and 85 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 39 clinical trials started and 52 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Saint Vincent Hospital Cancer Center at Saint Mary's" #1 sponsor was "National Cancer Institute (NCI)" with 100 trials, followed by "SWOG Cancer Research Network" with 26 trials sponsored, "Alliance for Clinical Trials in Oncology" with 15 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored and "NRG Oncology" with 10 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saint Vincent Hospital Cancer Center at Saint Mary's" #1 collaborator was "National Cancer Institute (NCI)" with 76 trials as a collaborator, "NRG Oncology" with 29 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 4 trials as a collaborator. Other collaborators include 28 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Saint Vincent Hospital Cancer Center at Saint Mary's" are "Recurrent Breast Carcinoma" (10 trials), "Invasive Breast Carcinoma" (9 trials), "Stage IV Breast Cancer AJCC v6 and v7" (9 trials), "Ovarian Seromucinous Carcinoma" (8 trials) and "Recurrent Ovarian Carcinoma" (8 trials). Many other conditions were trialed in "Saint Vincent Hospital Cancer Center at Saint Mary's" in a lesser frequency.

Most popular intervention types in "Saint Vincent Hospital Cancer Center at Saint Mary's" are "Drug" (139 trials), "Other" (131 trials), "Biological" (81 trials), "Procedure" (42 trials) and "Radiation" (33 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (76 trials), "Quality-of-Life Assessment" (54 trials), "Questionnaire Administration" (29 trials), "Paclitaxel" (26 trials) and "Carboplatin" (25 trials). Other intervention names were less common.

The vast majority of trials in "Saint Vincent Hospital Cancer Center at Saint Mary's" are 142 trials for "All" genders, 33 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Saint Vincent Hospital Cancer Center at Saint Mary's". undefined are not yet recruiting, 33 are recruiting, 94 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 41 completed trials in Saint Vincent Hospital Cancer Center at Saint Mary's, 6 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Saint Vincent Hospital Cancer Center at Saint Mary's, 6 "Phase 1" clinical trials were conducted, 77 "Phase 2" clinical trials and 105 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".